Jenny J. Li, M.D.

Peer-Reviewed Articles

1. Yamashita K, Sewastjanow-Silva M, Yoshimura K, Rogers JE, Rosa Vicentini E, Pool Pizzi M, Fan Y, Zou G, Li JJ, Blum Murphy M, Gan Q, Waters RE, Wang L, Ajani JA. SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel. Cancers (Basel) 16(7), 2024. e-Pub 2024. PMID: 38610978.
2. Hogenson TL, Xie H, Phillips WJ, Toruner MD, Li JJ, Horn IP, Kennedy DJ, Almada LL, Marks DL, Carr RM, Toruner M, Sigafoos AN, Koenig-Kappes AN, Olson RL, Tolosa EJ, Zhang C, Li H, Doles JD, Bleeker J, Barrett MT, Boyum JH, Kipp BR, Mahipal A, Hubbard JM, Scheffler Hanson TJ, Petersen GM, Dasari S, Oberg AL, Truty MJ, Graham RP, Levy MJ, Zhu M, Billadeau DD, Adjei AA, Dusetti N, Iovanna JL, Bekaii-Saab TS, Ma WW, Fernandez-Zapico ME. Culture media composition influences patient-derived organoids ability to predict therapeutic response in gastrointestinal cancers. JCI Insight. e-Pub 2022. PMID: 36256477.
3. Ma WW, Li JJ, Azad NS, Lam ET, Diamond JR, Dy GK, Opyrchal M, Zhi J, Kramer D, Chan WK, Cutler D, Kwan R, Adjei AA, Jimeno A. A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies. Cancer Chemother Pharmacol 90(1):7-17, 2022. e-Pub 2022. PMID: 35731258.
4. Li JJ, Zhang X, Sankar N, Espiritu L, Redkar S, Yu GL, Kizilbash SH. MET/HGF Coexpression as a Novel Predictive Biomarker for Response to MET Inhibitor Therapy in a Case of Psammomatous Melanotic Schwannoma. JCO Precis Oncol 6:e2200096, 2022. PMID: 35675576.
5. Li JJ, Kovach AR, DeMonia M, Slemmons KK, Oristian KM, Chen C, Linardic CM. Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence. Sci Rep 11(1):16505, 2021. e-Pub 2021. PMID: 34389744.
6. Bhulani N, Gupta A, Gao A, Li J, Guenther C, Ahn C, Paulk E, Houck S, Beg MS. Palliative care and end-of-life health care utilization in elderly patients with pancreatic cancer. J Gastrointest Oncol 9(3):495-502, 2018. PMID: 29998015.
7. Gupta A, Li J, Tawfik B, Pham T, Pathak S, Singh P, Porsa E, Sadeghi N, Li HC. Reducing Wait Time Between Admission and Chemotherapy Initiation. J Oncol Pract 14(5):e316-e323, 2018. e-Pub 2018. PMID: 29648922.
8. Li J, Di C, Jing J, Di Q, Nakhla J, Adamson DC. OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways. Int J Oncol 47(5):1703-10, 2015. e-Pub 2015. PMID: 26397460.

Invited Articles

1. Li JJ, Zhu M, Kashyap PC, Chia N, Tran NH, McWilliams RR, Bekaii-Saab TS, Ma WW. The role of microbiome in pancreatic cancer. Cancer Metastasis Rev 40(3):777-789, 2021. e-Pub 2021. PMID: 34455517.
2. Deel MD, Li JJ, Crose LE, Linardic CM. A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas. Front Oncol 5:190, 2015. e-Pub 2015. PMID: 26389076.
3. Mattox AK, Li J, Adamson DC. Stopping cancer in its tracks: using small molecular inhibitors to target glioblastoma migrating cells. Curr Drug Discov Technol 9(4):294-304, 2012. PMID: 22339073.
4. Li J, Di C, Mattox AK, Wu L, Adamson DC. The future role of personalized medicine in the treatment of glioblastoma multiforme. Pharmgenomics Pers Med 3:111-27, 2010. e-Pub 2010. PMID: 23226047.

Other Articles

1. Li JJ, Chen W, Sadeghi N Conjunctival lymphoma. BMJ Case Rep 12(7), 2019. PMID: 31296640.

Abstracts

1. Li JJ, Hsiao CL, Gao A, Syed SK, Unni N, Sadeghi N. Impact of dual anti-HER2 therapy on pathologic complete response rate in breast cancer in a minority-enriched population. J Clin Oncol 37(15_suppl), 2019.
2. Li JJ, Harper J, Zhu H, Bhulani N, Guenther CM, Madrigales A, Gates S, Kazmi SMA, Verma U, Toups M, Beg MS. Effective use of electronic medical record (EMR) data in analysis of association between KRAS mutations and depression in colorectal cancer patients. J Clin Oncol 36(suppl 4S), 2018.
3. Guenther CM, Bhulani N, Korenke A, Li JJ, Khosama L, Syed SK, Kazmi SMA, Cheedella NK, Karri S, Lohrey J, Sanjeevaiah A, Verma U, Cox JV, Arriaga YE, Beg MS. Prescribing patterns for FOLFIRINOX in the real world. J Clin Oncol 36(suppl 4S), 2018.
4. Bhulani N, Gao A, Gupta A, Chul A, Paulk ME, Houck S, Li JJ, Guenther CM, Kazmi SMA, Beg MS. Does timing of palliative care consults impact end-of-life health services utilization in pancreatic cancer patients?. J Clin Oncol 36(15_suppl), 2018.
5. Li JJ, Harper J, Bhulani N, Gerber DE, Khan SA, Madrigales A, Gates S, Toups M, Beg MS. Exploring the association between KRAS mutations and depression in non-small cell lung cancer (NSCLC) patients. J Clin Oncol 35(suppl 31S), 2017.

Book Chapters

1. Mattox A, Li J, Di C, Adamson DC. Medulloblastoma: Role of OTX2 Transcription Factors. In: Tumors of the Central Nervous System. 1. Springer: Netherlands, 47-58, 2012.